Send to a Friend Font Size: Increase Decrease

Clough Capital

Clough Capital's Portfolio

Last Updated on 5/17/11 @ 02:48pm

Ticker	# of Shares	Price	Value
	2,369,905	$195.32	$462,889,845
	1,260,697	$195.32	$246,239,339
	1,242,752	$195.32	$242,734,321
	1,070,900	$195.32	$209,168,188
	786,100	$195.32	$153,541,052
GOOG	350,190	$358.16	$125,424,051
	529,110	$195.32	$103,345,766
	510,382	$195.32	$99,687,813
	507,500	$195.32	$99,124,900
View Additional Portfolio Information »

Clough Capital Clough is a Boston-based investment advisory firm which manages approximately $3.9 billion in assets: $1.7 billion in hedge fund and institutional accounts; $92 million in open-end mutual funds; and $2.1 billion in three closed-end funds (as of February 28, 2011) - Clough Global Allocation (GLV), Clough Global Equity (GLQ), and the Clough Global Opportunities Fund (GLO). The firm uses a global and theme-based approach and invests in securities on a global basis. Clough was founded in 2000 by Chuck Clough and partners James Canty and Eric Brock. These three are the portfolio managers for the Clough Global Allocation Fund.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Apr 8, 2022 06:00AM CLOUGH GLOBAL DIVIDEND AND INCOME FUND DECLARES MONTHLY CASH DISTRIBUTIONS FOR APRIL, MAY AND JUNE 2022 OF $0.0906 PER SHARE
Feb 14, 2022 11:05AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 14, 2022 10:16AM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Jan 10, 2022 06:00AM CLOUGH GLOBAL EQUITY FUND DECLARES MONTHLY CASH DISTRIBUTIONS FOR JANUARY, FEBRUARY, AND MARCH 2022 OF $0.1162 PER SHARE
Jan 10, 2022 06:00AM CLOUGH GLOBAL OPPORTUNITIES FUND DECLARES MONTHLY CASH DISTRIBUTIONS FOR JANUARY, FEBRUARY, AND MARCH 2022 OF $0.0943 PER SHARE
Dec 21, 2021 05:13AM Sanofi (SNY) Acquires Amunix Immuno-Oncology Pipeline with Next-Gen Conditionally Activated Biologics
Dec 20, 2021 11:30PM Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics
Dec 20, 2021 11:30PM Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics
Nov 15, 2021 03:06PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Oct 8, 2021 06:00AM Clough Global Equity Fund Declares Monthly Cash Distributions for October, November, and December 2021 of $0.1341 per Share
Oct 8, 2021 06:00AM Clough Global Opportunities Fund Declares Monthly Cash Distributions for October, November, and December 2021 of $0.1087 Per Share
Oct 8, 2021 06:00AM Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for October, November, and December 2021 of $0.0967 per Share
Aug 16, 2021 10:58AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
Jul 9, 2021 06:00AM Clough Global Opportunities Fund Declares Monthly Cash Distributions for July, August, and September 2021 of $0.1087 per Share
Jul 9, 2021 06:00AM Clough Global Equity Fund Declares Monthly Cash Distributions For July, August, And September 2021 Of $0.1341 Per Share
Jul 9, 2021 06:00AM Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for July, August, and September 2021 of $0.0967 per Share
Jul 2, 2021 10:34AM Form 4 Clough Global Opportunit For: Jun 30 Filed by: Clough Capital Partners, L.P.
Jul 2, 2021 10:26AM Form 4 Clough Global Equity For: Jun 30 Filed by: Clough Capital Partners, L.P.
Jul 2, 2021 10:13AM Form 4 Clough Global Dividend For: Jun 30 Filed by: Clough Capital Partners, L.P.
Jun 29, 2021 04:30PM Clough Global Opportunities Fund Announces Final Results Of Rights Offering
Jun 29, 2021 04:30PM Clough Global Equity Fund Announces Final Results Of Rights Offering
Jun 29, 2021 04:30PM Clough Global Dividend And Income Fund Announces Final Results Of Rights Offering
Jun 23, 2021 06:30AM Clough Global Equity Fund Announces Preliminary Results Of Rights Offering
Jun 23, 2021 06:30AM Clough Global Opportunities Fund Announces Preliminary Results Of Rights Offering
Jun 23, 2021 06:30AM Clough Global Dividend And Income Fund Announces Preliminary Results Of Rights Offering
Jun 15, 2021 04:30PM Clough Capital Partners L.P. Announces Market Update Call
Jun 8, 2021 04:30PM Clough Capital Partners L.P. Announces Market Update Call
May 24, 2021 04:03PM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
May 20, 2021 08:25PM Form 4 Clough Global Dividend For: May 19 Filed by: Clough Capital Partners, L.P.
May 17, 2021 12:50PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
May 10, 2021 04:30PM Clough Global Opportunities Fund Announces Rights Offering
May 10, 2021 04:30PM Clough Global Dividend And Income Fund Announces Rights Offering
May 10, 2021 04:30PM Clough Global Equity Fund Announces Rights Offering
Apr 13, 2021 07:00AM Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies
Apr 13, 2021 07:00AM Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies
Apr 9, 2021 06:00AM Clough Global Opportunities Fund Declares Monthly Cash Distributions For April, May, And June 2021 Of $0.1087 Per Share
Apr 9, 2021 06:00AM Clough Global Equity Fund Declares Monthly Cash Distributions for April, May, and June 2021 of $0.1341 per Share
Apr 9, 2021 06:00AM Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for April, May, and June 2021 Of $0.0967 Per Share
Mar 4, 2021 08:00AM Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
Mar 4, 2021 08:00AM Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
Feb 16, 2021 12:49PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 12, 2021 12:22PM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Jan 8, 2021 06:00AM Clough Global Opportunities Fund Declares Monthly Cash Distributions for January, February, and March 2021 of $0.1087 Per Share
Jan 8, 2021 06:00AM Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, And March 2021 Of $0.1341 Per Share
Jan 8, 2021 06:00AM Clough Global Dividend And Income Fund Declares Monthly Cash Distributions For January, February, And March 2021 Of $0.0967 Per Share
Nov 17, 2020 06:03AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Nov 10, 2020 02:55PM Form SC 13G Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Oct 29, 2020 07:30AM Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
Oct 29, 2020 07:30AM Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
Oct 15, 2020 12:27PM Clough Capital Partners Strengthens Healthcare Research Capabilities with the Addition of Dr. Noelle Tune

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed